Cambrios lands $14.5M for electronic display components
Cambrios, maker of conductive films used in electronic displays and monitors, has brought in $14.5 million in a fourth round of venture capital. Based in Sunnyvale, Calif., the company is backed by ARCH Venture Partners, Alexandria Real Estate Equities, Alloy Ventures, Altitude Life Science Ventures, Avalon Ventures, Harris & Harris Group, Headland Ventures, In-Q-Tel, Kidron, Lux Capital, Mitsubishi UFJ Capital, Oxford Bioscience Partners, Presidio Ventures, Sumitomo, Chisso and Nissha Printing.
Scoopler gets seeded for real-time search
Scoopler, one of the newest companies providing real-time search capabilities, has brought in a seed round somewhere between $500,000 and $1 million. Based in San Francisco, the company was backed by Avalon Ventures, XG Ventures and high-profile individual investors Ron Conway and Michael Birch.
Scoopler, which scours Twitter, Digg and Delicious as their content is updated, first received funding last year from Y Combinator.
Cloudkick’s simple cloud management gets $750K
Updated
With more companies looking to move their applications onto cloud infrastructure, startups are emerging that offer services to facilitate that process. Cloudkick, for example, says it has built the easiest way manage your applications in the cloud, and it has just raised raised $750,000 in funding.
The San Jose, Calif. company was part of the winter class at startup incubator Y Combinator. When it launched in March, I thought it was one of the most promising… Continue Reading
Simulmedia launches today to bolster TV show promotions
Television channels spend a staggering $10 billion every year on commercial spots promoting their own shows. Riding this wave, Simulmedia launched today to increase the relevance of these ads and ultimately boost program ratings by better engaging viewers. The brainchild of Dave Morgan — founder of behavioral ad networks Tacoda and Real Media — the New York-based company just pulled in $4 million in first-round funding to ramp up operations.
Simulmedia will collect large stores of… Continue Reading
Awarepoint finds $13.3M for location-pinpointing platform
Location systems developer Awarepoint raked in $13.3 million in fourth-round financing to expand its domestic and international presence in the radio frequency identification (RFID) space. The San Diego company’s platform, utilizing this technology, is able to track the precise location and movement of people and things.
Cardinal Partners led the round, which also included Venrock and Avalon Ventures. Now five-years old, Awarepoint previously raised about $8 million.
Nabbr nabs $2.6M for social network marketing
Nabbr, a Chicago firm that specializes in digital marketing and widget development, brought in $2.57 million in a second round of funding from Allen & Co., Avalon Ventures and undisclosed others. The company has typically focused on widgets that market music on social networks but says it would like to diversify into other types of entertainment going forward. It has already produced apps used to advertise the films Iron Man and Mamma Mia. In the… Continue Reading
Investors find Chumby endearing as well with new $12.5 million round
Personal electronic devices with Internet connections are all the rage these days. A small, part touch-screen, part stuffed animal called Chumby is hands down the most endearing of these.
Chumby’s parent company, Chumby Industries, announced today a new round of financing to expand the reach of its cute device. Interestingly, the company is also looking to expand beyond the Chumby into other devices that use screen interaction such as digital picture frames and possibly even LCD… Continue Reading
Life-science briefing: Tuesday, March 25, 2008
TODAY’S HEADLINES:
Antibody-discovery startup Adimab raises new funding (release)
Lung-device maker Spiration gets $19M (release)
Sample-prep startup Protein Discovery pulls in $10M (release)
Inogen takes in $13M for portable oxygen device (VentureWire)
Healthcare IT concern Medaptus raises $11M for expansion (VentureWire)
Contract lab Synexis raises $14M (peHUB)
Medical-device VC firm BioStar Ventures takes in $24M of $80M fund (peHUB)
Halsa Pharma gets $250K for “natural” obesity-control treatment (release)
Diagnostics provider Lab21 acquires NPTech (peHUB)
Galil Medical names Martin Emerson CEO (release)
Antibody-discovery startup Adimab raises new funding – Lebanon,… Continue Reading
Life sciences briefing: Wednesday, Nov. 14, 2007
Featured companies: Advanced Bio-Surfaces, Ambit Biosciences, EnteroMedics, Molecular Vision, Skyline Ventures
UPDATED: Expanded items on Skyline Ventures, Ambit, and Molecular Vision, and moved EnteroMedics to a new item here.
Skyline Ventures raises $350M life-sciences fund — Skyline Ventures, a Palo Alto, Calif., VC firm, closed a $350 million fund for healthcare and life-sciences investments. The fund is Skyline’s fifth.
Skyline is unquestionably coming off a hot streak. As it notes in its release, three of its portfolio companies were acquired… Continue Reading
Life sciences briefing: Monday, Nov. 12, 2007
(UPDATED: See below.)
Featured companies: Anaptys Biosciences, Arterial Remodeling Technologies, Cambria Biosciences, CaseNet, ChemoCentryx, Ensemble Discovery, MediQuest, Piedmont Pharmaceuticals, Raven Biotechnologies, Sensys Medical, Verus Pharmaceuticals, Xanodyne Pharmaceuticals
UPDATED: Expanded items on Anaptys, Arterial Remodeling, Raven Biotech, Sensys and MediQuest. Moved ChemoCentryx and Xanodyne to a separate item.
Antibody-drug maker Raven Biotech merges with VaxGen — Raven Biotechnologies, a South San Francisco biotech developing antibody drugs, is merging with the troubled, publicly held vaccine maker VaxGen. The confusingly worded release is here.
Although… Continue Reading
BioVex raises $22M for cancer-killing viruses
Woburn, Mass.-based BioVex, a biotech working on new ways to attack cancer and infections, raised $22 million in a fifth funding round. Triathlon Medical Ventures led the round, joined by New Science Ventures, Forbion Capital Ventures, Avalon Ventures, Credit Agricole Private Equity, GeneChem Management, Innoven Partners and Scottish Equity Partners.
BioVex is developing so-called oncolytic viruses, which are designed to infect and destroy tumor cells — long a promising but never-proven anti-cancer technique. The company put… Continue Reading
InCode BioPharmaceutics raises $2M to target autoimmunity
InCode BioPharmaceutics, a Lahaina, Hawaii, biotech targeting autoimmune and inflammatory disease, raised $2 million in a second funding round, VentureWire reports (subscription required). The funding was provided by Avalon Ventures.
InCode is developing what VentureWire vaguely describes as “therapeutic uses for certain amino-acid sequences in non-human proteins,” which sounds like they’ve bioharvested some peptides from other organisms that seem to have interesting properties. The company said the funding will carry its lead compound, which it… Continue Reading
Vocera raises $7M more for wireless communication badges
Vocera Communications has raised another $7 million for its wearable Wireless communications badges, which let workers talk over distances via WiFi networks, VentureWire reports today (sub required).
The Cupertino company’s technology allows workers to press a button on a small badge, and ask for someone and the system recognizes who or what the worker is asking for, and makes the connection.
The company said it achieved a valuation above $100 million after the investment, and that the… Continue Reading